Orasis Pharmaceuticals

Orasis Pharmaceuticals is an ophthalmic pharmaceutical company focused on developing innovative solutions for vision problems. Their lead product, Qlosi, is a novel corrective eye drop for the treatment of presbyopia in adults, offering a balance of efficacy and tolerability. The company aims to reshape vision possibilities and provide relief from reading glasses.

Funding Round: Series D

Funding Amount: $78M

Date: 08-Oct-2024

Investors: Arboretum Ventures, Johnson & Johnson Innovation – JJDC, Inc., Catalio Capital Management, Freepoint Capital Group, Visionary Ventures, Bluestem Capital, SBI (Japan) Innovation Fund, Sequoia Capital, Maverick Ventures

Markets: Pharmaceuticals, Ophthalmic

HQ: Ponte Vedra Beach, Florida, United States

Founded: 2015

Website: http://www.orasis-pharma.com/

LinkedIn: https://www.linkedin.com/company/orasis-pharmaceuticals/

Twitter: https://twitter.com/OrasisPharma

Instagram:

Facebook: https://www.facebook.com/OrasisPharma

Crunchbase: https://www.crunchbase.com/organization/orasis-pharmaceuticals

Pitchbook: https://pitchbook.com/profiles/company/187751-26